Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Osteoarthritis Cartilage. 2022 Jan 11;30(4):559–569. doi: 10.1016/j.joca.2021.12.010

Figure 2. Time to Knee Replacement over Five Years for the Propensity-score Matched Cohorts of Knee Osteoarthritis Patients with Initiation of (A) Omeprazole, (B) Pantoprazole, (C) Lansoprazole, (D) Rabeprazole, or (E) Esomeprazole Compared with Initiation of H2RA adjusting for Competing Risk of Death.

Figure 2.

Figure 2.

Figure 2.

Figure 2.

Figure 2.

H2RA, Histamine-2 receptor antagonist.